ITGA9-SEC13 Fusion FISH Probe
The ITGA9-SEC13 Fusion FISH Probe is used to confirm a fusion of the ITGA9 and SEC13 genes. The fusion of the ITGA9 and SEC13 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ITGA9-SEC13-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ITGA9-SEC13-20-AQAQ | 20 (40 μL) | 200 μL |
|
ITGA9 Gene Summary
This gene encodes an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers. [provided by RefSeq, Jul 2008]
Gene Name: Integrin Subunit Alpha 9
Chromosome: CHR3: 37493812 -37861281
Locus: 3p22.2
SEC13 Gene Summary
The protein encoded by this gene belongs to the SEC13 family of WD-repeat proteins. It is a constituent of the endoplasmic reticulum and the nuclear pore complex. It has similarity to the yeast SEC13 protein, which is required for vesicle biogenesis from endoplasmic reticulum during the transport of proteins. Multiple alternatively spliced transcript variants have been found. [provided by RefSeq, Oct 2008]
Gene Name: SEC13 Homolog, Nuclear Pore And COPII Coat Complex Component
Chromosome: CHR3: 10342614 -10362858
Locus: 3p25.3
Gene Diseases
The ITGA9 SEC13 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|